|
Psychiatric Genomics, Inc |
|
|
|
|
Psychiatric Genomics, Inc.
Psychiatric Genomics
creates and develops innovative small molecule drugs to treat mental illness.
Many of these diseases such as bipolar disorder, schizophrenia, depression, and
autism can be attributed to genetic factors. Using human tissues, the company
identifies gene expression patterns associated with psychiatric diseases. These
data are incorporated into Psychiatric Genomics' proprietary Multi-Parameter
High Throughput ScreenSM (MPHTSSM) method to rapidly
discover unique therapeutic compounds.
At Psychiatric Genomics, Inc., we are working to create and
develp innovative small molecule drugs to treat mental illness. As a member of
this team, located in the Washington, DC metro area, you could profit from a
scientifically charged environment while taking part in a ground-breaking
opportunity.
Psychiatric Genomics, Inc.
Human Resources
19 Firstfield Road
Gaithersburg, Maryland 20878
Fax: 301 556-1350
e-mail:
careers@psygenomics.com
|
